Cyanotech Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Cyanotech.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Personal Products	23.3%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Cyanotech Corporation (NASDAQ:CYAN) Not Doing Enough For Some Investors As Its Shares Slump 39%

Feb 15

Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?

Feb 09

Is Cyanotech (NASDAQ:CYAN) Weighed On By Its Debt Load?

Oct 05

There's Been No Shortage Of Growth Recently For Cyanotech's (NASDAQ:CYAN) Returns On Capital

Sep 30

These 4 Measures Indicate That Cyanotech (NASDAQ:CYAN) Is Using Debt Reasonably Well

Feb 08

Returns On Capital Tell Us A Lot About Cyanotech (NASDAQ:CYAN)

Jan 04

Cyanotech Corporation's (NASDAQ:CYAN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 30

Cyanotech reports Q2 results

Nov 12

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Cyanotech no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

OTCPK:CYAN - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2023	22	-5	-1	0	N/A
9/30/2023	23	-4	0	1	N/A
6/30/2023	22	-4	-2	-1	N/A
3/31/2023	23	-3	-3	-2	N/A
12/31/2022	26	-2	-3	-2	N/A
9/30/2022	29	-1	-2	-1	N/A
6/30/2022	34	1	1	3	N/A
3/31/2022	36	2	1	2	N/A
12/31/2021	37	2	2	3	N/A
9/30/2021	35	2	1	2	N/A
6/30/2021	34	1	0	1	N/A
3/31/2021	32	1	2	2	N/A
12/31/2020	32	1	1	2	N/A
9/30/2020	32	1	3	3	N/A
6/30/2020	31	1	2	2	N/A
3/31/2020	32	0	1	1	N/A
12/31/2019	29	-1	-1	-1	N/A
9/30/2019	32	-1	0	0	N/A
6/30/2019	31	-2	-1	-1	N/A
3/31/2019	30	-4	-1	-1	N/A
12/31/2018	32	-3	-1	0	N/A
9/30/2018	31	-2	-2	-1	N/A
6/30/2018	32	-1	-1	0	N/A
3/31/2018	34	1	0	1	N/A
12/31/2017	33	2	1	2	N/A
9/30/2017	32	0	N/A	2	N/A
6/30/2017	34	0	N/A	1	N/A
3/31/2017	32	-1	N/A	1	N/A
12/31/2016	33	-5	N/A	1	N/A
9/30/2016	33	-5	N/A	2	N/A
6/30/2016	32	-5	N/A	1	N/A
3/31/2016	32	-4	N/A	1	N/A
12/31/2015	32	-1	N/A	2	N/A
9/30/2015	34	0	N/A	1	N/A
6/30/2015	34	0	N/A	1	N/A
3/31/2015	34	0	N/A	1	N/A
12/31/2014	32	0	N/A	3	N/A
9/30/2014	30	-1	N/A	2	N/A
6/30/2014	29	-1	N/A	2	N/A
3/31/2014	28	0	N/A	2	N/A
12/31/2013	29	3	N/A	1	N/A
9/30/2013	28	3	N/A	1	N/A
6/30/2013	28	4	N/A	1	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de CYAN es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de CYAN crezcan más rápidamente que el mercado US

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de CYAN crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de CYAN crezcan más rápidamente que el mercado de US.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de CYAN crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de CYAN se prevé que sea elevada dentro de 3 años.

Cyanotech Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

The Nasdaq Stock Market to Delist the Common Stock of Cyanotech

Cyanotech Corporation(NasdaqCM:CYAN) dropped from NASDAQ Composite Index

Cyanotech Corporation(NasdaqCM:CYAN) dropped from NASDAQ Composite Index

New minor risk - Share price stability

Cyanotech Corporation (NASDAQ:CYAN) Not Doing Enough For Some Investors As Its Shares Slump 39%

Cyanotech Receives Notification Letter from The Nasdaq Stock Market LLC Regarding Not Regains Compliance with the Bid Price Rule and Not Eligible for Second 180-Day Period

New major risk - Financial position

Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?

Third quarter 2024 earnings released: US$0.16 loss per share (vs US$0.095 loss in 3Q 2023)

Second quarter 2024 earnings released: US$0.13 loss per share (vs US$0.15 loss in 2Q 2023)

Is Cyanotech (NASDAQ:CYAN) Weighed On By Its Debt Load?

First quarter 2024 earnings released: US$0.22 loss per share (vs US$0.076 loss in 1Q 2023)

Cyanotech Receives Notification Letter from Nasdaq Regarding Non-Compliance with Minimum Bid Price Requirement for its Common Stock

Cyanotech Corporation Appoints Collette Kakuk as Chief Strategic and Commercial Officer

Cyanotech Corporation, Annual General Meeting, Aug 24, 2023

New minor risk - Share price stability

Full year 2023 earnings released: US$0.55 loss per share (vs US$0.35 profit in FY 2022)

Cyanotech Receives a Notification Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC Regarding Bid Price Rule

Third quarter 2023 earnings released: US$0.095 loss per share (vs US$0.062 profit in 3Q 2022)

Second quarter 2023 earnings released: US$0.15 loss per share (vs US$0.16 profit in 2Q 2022)

Investor sentiment improved over the past week

There's Been No Shortage Of Growth Recently For Cyanotech's (NASDAQ:CYAN) Returns On Capital

Investor sentiment deteriorated over the past week

Here's Why Cyanotech (NASDAQ:CYAN) Can Manage Its Debt Responsibly

First quarter 2023 earnings released: US$0.076 loss per share (vs US$0.085 profit in 1Q 2022)

Cyanotech GAAP EPS of -$0.08, revenue of $6.72M

Cyanotech Corporation, Annual General Meeting, Aug 25, 2022

Cyanotech Corporation Announces Management Changes

Full year 2022 earnings released: EPS: US$0.35 (vs US$0.15 in FY 2021)

Cyanotech (NASDAQ:CYAN) Might Have The Makings Of A Multi-Bagger

Is Cyanotech (NASDAQ:CYAN) A Risky Investment?

Insufficient new directors

The ESG Future Of Food Protein Production: Cyanotech

Cyanotech (NASDAQ:CYAN) Is Doing The Right Things To Multiply Its Share Price

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

We Think Cyanotech (NASDAQ:CYAN) Can Stay On Top Of Its Debt

Independent Chairman of the Board recently bought US$126k worth of stock

Cyanotech (NASDAQ:CYAN) Is Experiencing Growth In Returns On Capital

Second quarter 2022 earnings released: EPS US$0.16 (vs US$0.026 in 2Q 2021)

First quarter 2022 earnings released: EPS US$0.085 (vs US$0.023 in 1Q 2021)

Full year 2021 earnings released: EPS US$0.15 (vs US$0.065 in FY 2020)

Cyanotech (NASDAQ:CYAN) Is Carrying A Fair Bit Of Debt

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: US$4.12

Cyanotech's (NASDAQ:CYAN) Promising Earnings May Rest On Soft Foundations

Third quarter 2021 earnings released: EPS US$0.14 (vs US$0.029 in 3Q 2020)

New 90-day high: US$3.92

These 4 Measures Indicate That Cyanotech (NASDAQ:CYAN) Is Using Debt Reasonably Well

New 90-day high: US$3.40

New 90-day high: US$3.22

Returns On Capital Tell Us A Lot About Cyanotech (NASDAQ:CYAN)

New 90-day high: US$3.17

Cyanotech Corporation's (NASDAQ:CYAN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Independent Director recently sold US$108k worth of stock

Second quarter 2021 earnings released: EPS US$0.026

Cyanotech reports Q2 results

Market bids up stock over the past week

Market bids up stock over the past week

Cyanotech Corporation Launches Bioastin

New 90-day high - US$2.85

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento